AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas

被引:0
|
作者
Caitlin D. May
Jeannine Garnett
XiaoYan Ma
Sharon M. Landers
Davis R. Ingram
Elizabeth G. Demicco
Ghadah A. Al Sannaa
Tona Vu
Lixia Han
Yi Zhang
Christine M. Kivlin
Svetlana Bolshakov
Azad Abul Kalam
Juehui Liu
Fuguo Zhou
Dominique Broccoli
Wei-Lien Wang
Alexander J. Lazar
Raphael E. Pollock
Dina Lev
Keila E. Torres
机构
[1] The University of Texas MD Anderson Cancer Center,Department of Surgical Oncology
[2] The University of Texas Health Science Center at Houston Graduate School of Biomedical Sciences,Department of Pathology
[3] The University of Texas MD Anderson Cancer Center,Department of Cancer Biology
[4] The University of Texas MD Anderson Cancer Center,Department of Surgery
[5] Curtis and Elizabeth Anderson Cancer Institute,Department of Surgery, Sheba Medical Center
[6] Memorial University Medical Center,undefined
[7] The Ohio State University,undefined
[8] Tel Aviv University,undefined
来源
BMC Cancer | / 15卷
关键词
AXL; Receptor tyrosine kinase; Liposarcoma; Soft tissue sarcoma;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas
    May, Caitlin D.
    Garnett, Jeannine
    Ma, XiaoYan
    Landers, Sharon M.
    Ingram, Davis R.
    Demicco, Elizabeth G.
    Al Sannaa, Ghadah A.
    Vu, Tona
    Han, Lixia
    Zhang, Yi
    Kivlin, Christine M.
    Bolshakov, Svetlana
    Abul Kalam, Azad
    Liu, Juehui
    Zhou, Fuguo
    Broccoli, Dominique
    Wang, Wei-Lien
    Lazar, Alexander J.
    Pollock, Raphael E.
    Lev, Dina
    Torres, Keila E.
    BMC CANCER, 2015, 15
  • [2] Distinct chromosomal imbalances in pleomorphic and in high-grade dedifferentiated liposarcomas
    Rieker, RJ
    Joos, S
    Bartsch, C
    Willeke, F
    Schwarzbach, M
    Otaño-Joos, M
    Ohl, S
    Högel, J
    Lehnert, T
    Lichter, P
    Otto, HF
    Mechtersheimer, G
    INTERNATIONAL JOURNAL OF CANCER, 2002, 99 (01) : 68 - 73
  • [3] Are Peripheral Pure Pleomorphic Sarcomas with MDM2 Amplification Dedifferentiated Liposarcomas?
    Le Guellec, S.
    Neuville, A.
    Chibon, F.
    Ranchere-Vince, D.
    Larousserie, F.
    Terrier, P.
    Coindre, J-M
    MODERN PATHOLOGY, 2013, 26 : 16A - 16A
  • [4] Are Peripheral Pure Pleomorphic Sarcomas with MDM2 Amplification Dedifferentiated Liposarcomas?
    Le Guellec, S.
    Neuville, A.
    Chibon, F.
    Ranchere-Vince, D.
    Larousserie, F.
    Terrier, P.
    Coindre, J-M
    LABORATORY INVESTIGATION, 2013, 93 : 16A - 16A
  • [5] Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas
    Lee, Jen-Chieh
    Jeng, Yung-Ming
    Liau, Jau-Yu
    Tsai, Jia-Huei
    Hsu, Hung-Han
    Yang, Ching-Yao
    MODERN PATHOLOGY, 2015, 28 (08) : 1064 - 1073
  • [6] Dedifferentiated liposarcomas: evaluation of the prognostic and therapeutic factors in the elderly patient
    C Amodeo
    P Caglia’
    A Tracia
    S Costa
    V Russo
    B Lucifora
    L Borzi’
    E Zappulla
    BMC Geriatrics, 10 (Suppl 1)
  • [7] Are Peripheral Purely Undifferentiated Pleomorphic Sarcomas With MDM2 Amplification Dedifferentiated Liposarcomas?
    Le Guellec, Sophie
    Chibon, Frederic
    Ouali, Monia
    Perot, Gaelle
    Decouvelaere, Anne-Valerie
    Robin, Yves-Marie
    Larousserie, Frederique
    Terrier, Philippe
    Coindre, Jean-Michel
    Neuville, Agnes
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2014, 38 (03) : 293 - 304
  • [8] Dedifferentiated cecal liposarcomas
    Darouichi, M.
    FEUILLETS DE RADIOLOGIE, 2011, 51 (02) : 70 - 76
  • [9] Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis
    Li, Y.
    Ye, X.
    Tan, C.
    Hongo, J-A
    Zha, J.
    Liu, J.
    Kallop, D.
    Ludlam, M. J. C.
    Pei, L.
    ONCOGENE, 2009, 28 (39) : 3442 - 3455
  • [10] Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis
    Y Li
    X Ye
    C Tan
    J -A Hongo
    J Zha
    J Liu
    D Kallop
    M J C Ludlam
    L Pei
    Oncogene, 2009, 28 : 3442 - 3455